Role of p53 in mitochondrial biogenesis and apoptosis in skeletal muscle

Physiological Genomics

Volumn 37, Issue 1, 2009, Pages 58-66

  Saleem, Ayesha ^a,b   Adhihetty, Peter J ^a,b   Hood, David A ^a,b  

^a YORK UNIVERSITY   (Canada)

^b YORK UNIVERSITY   (Canada)

Author keywords

Endurance exercise; Fatigue; Mitochondrial turnover; Signaling cascades

Indexed keywords

CYTOCHROME C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOGENESIS; BREATHING; CONTROLLED STUDY; DNA FRAGMENTATION; EXERCISE; KINETICS; KNOCKOUT MOUSE; LOCOMOTION; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MOUSE; MUSCLE CONTRACTION; MUSCLE FUNCTION; MUSCLE STRENGTH; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WILD TYPE;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; BODY WEIGHT; FATIGUE; KINETICS; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MUSCLE CONTRACTION; MUSCLE, SKELETAL; ORGAN SIZE; PHOSPHOSERINE; PHYSICAL CONDITIONING, ANIMAL; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MUS;

EID: 66249089036     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.90346.2008     Document Type: Article

References (49)

1. Achanta G, Sasaki R, Feng L, Carew JS, Lu W, Pelicano H, Keating MJ, Huang P. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J 24: 3482-3492, 2005.
2. Adhihetty PJ, Irrcher I, Joseph AM, Ljubicic V, Hood DA. Plasticity of skeletal muscle mitochondria in response to contractile activity. Exp Physiol 88: 99-107, 2003.
3. Adhihetty PJ, Ljubicic V, Hood DA. Effect of chronic contractile activity on SS and IMF mitochondrial apoptotic susceptibility in skeletal muscle. Am J Physiol Endocrinol Metab 292: E748-E755, 2007.
4. Adhihetty PJ, Ljubicic V, Menzies KJ, Hood DA. Differential susceptibility of subsarcolemmal and intermyofibrillar mitochondria to apoptotic stimuli. Am J Physiol Cell Physiol 289: C994-C1001, 2005.
5. Adhihetty PJ, O'Leary MF, Chabi B, Wicks KL, Hood DA. Effect of denervation on mitochondrially mediated apoptosis in skeletal muscle. J Appl Physiol 102: 1143-1151, 2007.
6. Amson R, Lassalle JM, Halley H, Prieur S, Lethrosne F, Roperch JP, Israeli D, Gendron MC, Duyckaerts C, Checler F, Dausset J, Cohen D, Oren M, Telerman A. Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice. Proc Natl Acad Sci USA 97: 5346-5350, 2000.
7. Bates S, Vousden KH. Mechanisms of p53-mediated apoptosis. Cell Mol Life Sci 55: 28 -37, 1999.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248 -254, 1976.
9. Campana AL, Rondi-Reig L, Tobin C, Lohof AM, Picquet F, Fale- mpin M, Weitzman JB, Mariani J. p53 inactivation leads to impaired motor synchronization in mice. Eur J Neurosci 17: 2135-2146, 2003.
10. Chang NS. A potential role of p53 and WOX1 in mitochondrial apoptosis. Int J Mol Med 9: 19-24, 2002.
11. Chouinard N, Valerie K, Rouabhia M, Huot J. UVB-mediated activation of p38 mitogen-activated protein kinase enhances resistance of normal human keratinocytes to apoptosis by stabilizing cytoplasmic p53. Biochem J 365: 133-145, 2002.
12. Cogswell AM, Stevens RJ, Hood DA. Properties of skeletal muscle mitochondria isolated from subsarcolemmal and intermyofibrillar regions. Am J Physiol Cell Physiol 264: C383-C389, 1993.
13. Connor MK, Bezborodova O, Escobar CP, Hood DA. Effect of contractile activity on protein turnover in skeletal muscle mitochondrial subfractions. J Appl Physiol 88: 1601-1606, 2000.
14. Cooperstein SJ, Lazarow A. A microspectrophotometric method for the determination of cytochrome oxidase. J Biol Chem 189: 665-670, 1951.
15. Donahue RJ, Razmara M, Hoek JB, Knudsen TB. Direct influence of the p53 tumor suppressor on mitochondrial biogenesis and function. FASEB J 15: 635-644, 2001.
16. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel S, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221, 1992.
17. Fields J, Hanisch JJ, Choi JW, Hwang PM. How does p53 regulate mitochondrial respiration? IUBMB Life 59: 682-684, 2007.
18. Heyne K, Mannebach S, Wuertz E, Knaup KX, Mahyar-Roemer M, Roemer K. Identification of a putative p53 binding sequence within the human mitochondrial genome. FEBS Lett 578: 198-202, 2004.
19. Hood DA. Contractile activity-induced mitochondrial biogenesis in skeletal muscle. J Appl Physiol 90: 1137-1157, 2001.
20. Hood DA, Irrcher I, Ljubicic V, Joseph AM. Coordination of metabolic plasticity in skeletal muscle. J Exp Biol 209: 2265-2275, 2006.
21. Hood DA, Saleem A. Exercise-induced mitochondrial biogenesis in skeletal muscle. Nutr Metab Cardiovasc Dis 17: 332-337, 2007.
22. Hu W, Feng Z, Teresky AK, Levine AJ. p53 regulates maternal reproduction through LIF. Nature 450: 721-724, 2007.
23. Irrcher I, Adhihetty PJ, Joseph AM, Ljubicic V, Hood DA. Regulation of mitochondrial biogenesis in muscle by endurance exercise. Sports Med 33: 783-793, 2003.
24. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18: 283-293, 2005.
25. Levine AJ, Hu W, Feng Z. The p53 pathway: what questions remain to be explored? Cell Death Differ 13: 1027-1036, 2006.
26. Ljubicic V, Adhihetty PJ, Hood DA. Role of UCP3 in state 4 respiration during contractile activity-induced mitochondrial biogenesis. J Appl Physiol 97: 976-983, 2004.
27. Ma W, Sung HJ, Park JY, Matoba S, Hwang PM. A pivotal role for p53: balancing aerobic respiration and glycolysis. J Bioenerg Biomembr 39: 243-246, 2007.
28. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM. p53 regulates mitochondrial respiration. Science 312: 1650-1653, 2006.
29. Michael D, Oren M. The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 13: 49-58, 2003.
30. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11: 577-590, 2003.
31. Moll UM, Zaika A. Nuclear and mitochondrial apoptotic pathways of p53. FEBS Lett 493: 65-69, 2001.
32. Okamura S, Ng CC, Koyama K, Takei Y, Arakawa H, Monden M, Nakamura Y. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system. Oncol Res 11: 281-285, 1999.
33. Reznick RM, Shulman GI. The role of AMP-activated protein kinase in mitochondrial biogenesis. J Physiol 574: 33-39, 2006.
34. Schuler M, Green DR. Mechanisms of p53-dependent apoptosis. Bio- chem Soc Trans 29: 684-688, 2001.
35. She QB, Bode AM, Ma WY, Chen NY, Dong Z. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 61: 1604 -1610, 2001.
36. Sheikh MS, Fornace AJ Jr. Role of p53 family members in apoptosis. J Cell Physiol 182: 171-181, 2000.
37. Siu PM, Alway SE. Mitochondria-associated apoptotic signalling in denervated rat skeletal muscle. J Physiol 565: 309 -323, 2005.
38. Siu PM, Pistilli EE, Murlasits Z, Alway SE. Hindlimb unloading increases muscle content of cytosolic but not nuclear Id2 and p53 proteins in young adult and aged rats. J Appl Physiol 100: 907-916, 2006.
39. Stambolsky P, Weisz L, Shats I, Klein Y, Goldfinger N, Oren M, Rotter V. Regulation of AIF expression by p53. Cell Death Differ 13: 2140-2149, 2006.
40. Takahashi M, Hood DA. Chronic stimulation-induced changes in mitochondria and performance in rat skeletal muscle. J Appl Physiol 74:934-941, 1993.
41. Takahashi M, Hood DA. Protein import into subsarcolemmal and inter- myofibrillar skeletal muscle mitochondria. Differential import regulation in distinct subcellular regions. J Biol Chem 271: 27285-27291, 1996.
42. Takahashi M, McCurdy DT, Essig DA, Hood DA. delta-Aminolaevu- linate synthase expression in muscle after contractions and recovery. Biochem J 291: 219-223, 1993.
43. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 408: 307-310, 2000.
44. Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol 8: 275-283, 2007.
45. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39: 359-407, 2005.
46. Winder WW, Holmes BF, Rubink DS, Jensen EB, Chen M, Holloszy JO. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 88: 2219-2226, 2000.
47. Yoshida Y, Izumi H, Torigoe T, Ishiguchi H, Itoh H, Kang D, Kohno K. p53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res 63: 3729-3734, 2003.
48. Yu J, Zhang L. The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 331: 851-858, 2005.
49. Zhou S, Kachhap S, Singh KK. Mitochondrial impairment in p53- deficient human cancer cells. Mutagenesis 18: 287-292, 2003.